VIRIDIAN THERAPEUTICS INC. - COMMON STOCK

Viridian Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Updates

11 أغسطس 2021 07:00:01 بحسب Nasdaq GlobeNewswire

Viridian Therapeutics to Participate in the Wedbush PacGrow Healthcare Virtual Conference

05 أغسطس 2021 08:30:00 بحسب Nasdaq GlobeNewswire

Viridian Therapeutics Appoints Kristian Humer as Chief Financial Officer and Chief Business Officer

26 يوليو 2021 07:30:00 بحسب Nasdaq GlobeNewswire

Viridian Therapeutics Appoints Jennifer Moses, CPA to the Board of Directors and as Chair of the Audit Committee

15 يوليو 2021 16:05:00 بحسب Nasdaq GlobeNewswire

Viridian Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

14 يوليو 2021 08:00:01 بحسب Nasdaq GlobeNewswire

Viridian Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference

07 يوليو 2021 08:00:01 بحسب Nasdaq GlobeNewswire

Viridian Therapeutics to Participate in the JMP Securities Life Sciences Conference

10 يونيو 2021 08:00:01 بحسب Nasdaq GlobeNewswire

Viridian Therapeutics to Participate in Upcoming Investor Conferences

14 مايو 2021 08:00:00 بحسب Nasdaq GlobeNewswire

Viridian Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Updates

06 مايو 2021 16:05:01 بحسب Nasdaq GlobeNewswire

Viridian Therapeutics Reports 2020 Financial Results and Provides Corporate Updates

25 مارس 2021 16:05:00 بحسب Nasdaq GlobeNewswire

Viridian Therapeutics To Host Conference Call Discussing Fourth Quarter And Full Year 2020 Results And Corporate Update

09 مارس 2021 16:30:00 بحسب Nasdaq GlobeNewswire